While there appeared to be no apparent adverse actions based on the topical application to skin, Ki-67 staining of the tumor sections, a marker for cell proliferation, revealed highly active proliferation in the tumor during vehicle treatment (Figure 9A). Here, MKI67 is linked to neoplasm.